Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2021 Mar;64(3):561-570.
doi: 10.1007/s00125-020-05331-0. Epub 2020 Nov 16.

Hyperglycemia and Adverse Pregnancy Outcome Follow-Up Study: newborn anthropometrics and childhood glucose metabolism

Affiliations
Multicenter Study

Hyperglycemia and Adverse Pregnancy Outcome Follow-Up Study: newborn anthropometrics and childhood glucose metabolism

Monica E Bianco et al. Diabetologia. 2021 Mar.

Erratum in

Abstract

Aims/hypothesis: We aimed to examine associations of newborn anthropometric measures with childhood glucose metabolism with the hypothesis that greater newborn birthweight, adiposity and cord C-peptide are associated with higher childhood glucose levels and lower insulin sensitivity.

Methods: Data from the international, multi-ethnic, population-based Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study and the HAPO Follow-Up Study were used. The analytic cohort included 4155 children (mean age [SD], 11.4 [1.2] years; 51.0% male). Multiple linear regression was used to examine associations of primary predictors, birthweight, newborn sum of skinfolds (SSF) and cord C-peptide, from HAPO with continuous child glucose outcomes from the HAPO Follow-Up Study.

Results: In an initial model that included family history of diabetes and maternal BMI during pregnancy, birthweight and SSF demonstrated a significant, inverse association with 30 min and 1 h plasma glucose levels. In the primary model, which included further adjustment for maternal sum of glucose z scores from an oral glucose tolerance test during pregnancy, the associations were strengthened, and birthweight and SSF were inversely associated with fasting, 30 min, 1 h and 2 h plasma glucose levels. Birthweight and SSF were also associated with higher insulin sensitivity (Matsuda index) (β = 1.388; 95% CI 0.870, 1.906; p < 0.001; β = 0.792; 95% CI 0.340, 1.244; p < 0.001, for birthweight and SSF higher by 1 SD, respectively) in the primary model, while SSF, but not birthweight, was positively associated with the disposition index, a measure of beta cell compensation for insulin resistance (β = 0.034; 95% CI 0.012, 0.056; p = 0.002). Cord C-peptide levels were inversely associated with Matsuda index (β = -0.746; 95% CI -1.188, -0.304; p < 0.001 for cord C-peptide higher by 1 SD) in the primary model.

Conclusions/interpretation: This study demonstrates that higher birthweight and SSF are associated with greater childhood insulin sensitivity and lower glucose levels following a glucose load, associations that were further strengthened after adjustment for maternal glucose levels during pregnancy. Graphical abstract.

Keywords: Birthweight; Childhood glucose metabolism; Childhood plasma glucose; Fetal exposures; Newborn adiposity; Newborn anthropometrics.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Association of birthweight, newborn SSF and cord C-peptide with childhood insulin sensitivity and oDI. The β values (95% CIs) for newborn birthweight (a), SSF (b) and cord C-peptide (c) higher by 1 SD with the Matsuda index are shown, as are associations of birthweight (d), SSF (e) and cord C-peptide (f) higher by 1 SD with oDI. Results are presented for each outcome for model 1 (M01, red) and model 2 (M02, blue)
Fig. 2
Fig. 2
Measures of glucose metabolism across SSF thickness quantiles. Quantiles of SSF ranging from <10th percentile to >90th percentile were determined. The mean ± SEM of fasting (a), 30 min (b), 1 h (c) and 2 h (d) glucose as well as the Matsuda index (e) and oDI (f) across the quantiles of SSF were determined

References

    1. Dabelea D, Mayer-Davis EJ, Saydah S, et al. (2014) Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. JAMA 311: 1778–1786 - PMC - PubMed
    1. Imperatore G, Boyle JP, Thompson TJ, et al. (2012) Projections of type 1 and type 2 diabetes burden in the U.S. population aged <20 years through 2050: dynamic modeling of incidence, mortality, and population growth. Diabetes Care 35: 2515–2520 - PMC - PubMed
    1. The RISE Consortium (2018) Metabolic Contrasts Between Youth and Adults With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes: I. Observations Using the Hyperglycemic Clamp. Diabetes Care 41: 1696–1706 - PMC - PubMed
    1. TODAY Study Group, Zeitler P, Hirst K, et al. (2012) A clinical trial to maintain glycemic control in youth with type 2 diabetes. N Engl J Med 366: 2247–2256 - PMC - PubMed
    1. TODAY Study Group (2013) Effects of metformin, metformin plus rosiglitazone, and metformin plus lifestyle on insulin sensitivity and beta-cell function in TODAY. Diabetes Care 36: 1749–1757 - PMC - PubMed

Publication types

MeSH terms